HONG KONG – Taking another step to strengthen its presence in the promising Chinese market, South Korea-based Hanmi Science Co. Ltd. (KS:008930) will pour about $200 million into a new plant in the fast growing neighboring market.

HONG KONG – A recent scandal involving the illegal sales of vaccines has further eroded the trust of the Chinese public, particularly parents, toward drug safety and the government's loophole-ridden supervision of the space.

HONG KONG – As part of an effort to step up as a precision medicine powerhouse, the Chinese government is moving forward on an initiative that would see it provide billions of dollars in funding over the next 15 years.

TOKYO – A long-standing and wide divide between Japan’s academia and the country’s pharmaceutical industry is resulting in top-notch research being left behind in university labs and science journals. Patients, of course, have the most at stake in this disconnected environment.

TOKYO – With a liberalized regulatory environment, Japan is rapidly emerging as a major player in regenerative medicine and is attracting more companies eager to explore the market.

TOKYO – A long-standing and wide divide between Japan's academia and the country's pharmaceutical industry is resulting in top-notch research being left behind in university labs and science journals. Patients, of course, have the most at stake in this disconnected environment.